Results 151 to 160 of about 113,976,979 (200)

Waning in influenza vaccine effectiveness against influenza A(H1N1)pdm09-associated hospitalization in children in 2012/2013. [PDF]

Epidemiol Infect
Chua HY, Tsang TK, Lee SL, Chan ELY, Kwan MYW, Wong JSC, Peiris M, Sullivan SG, Cowling BJ.   +8 more
europepmc   +1 more source

Influenza A(H1N1)pdm09 Virus Alters Expression of Endothelial Factors in Pulmonary Vascular Endothelium in Rats. [PDF]

Viruses, 2022
Marchenko V, Mukhametdinova D, Amosova I, Lioznov D, Zhilinskaya I.   +4 more
europepmc   +1 more source

An interseasonal outbreak of influenza A(H1N1)pdm09 related to a music festival, Denmark, August 2025. [PDF]

Euro Surveill
Bolt Botnen A, Emborg HD, Thorup C, Krog J, Myrup Otero S, Nielsen S, Søborg B, Trebbien R.   +7 more
europepmc   +1 more source

Expansion of influenza A(H1N1)pdm09 NA:S247N viruses with reduced susceptibility to oseltamivir, Catalonia, Spain, and in Europe, July to October 2025. [PDF]

Euro Surveill
Saubi N, Andrés C, Prats-Méndez I, González-Sánchez A, Davtyan A, Vásquez-Mercado R, Rando A, Nadal P, Esperalba J, Arnedo M, Vicente M, Balada E, Mendioroz J, Martín MC, García-Camuñas K, Vaz R, Najarro A, Bernalte S, Larrosa N, Antón A, SIVIC Infectious diseases sentinel network.   +20 more
europepmc   +1 more source

Influenza A(H1N1)pdm09 Virus with Reduced Susceptibility to Baloxavir, Japan, 2024. [PDF]

Emerg Infect Dis
Takashita E, Morita H, Nagata S, Fujisaki S, Miura H, Ikeda T, Komabayashi K, Sasaki M, Matoba Y, Takahashi T, Ogawa N, Mizuta K, Ito S, Kishida N, Nakamura K, Shirakura M, Watanabe S, Hasegawa H.   +17 more
europepmc   +1 more source

Low quality antibody responses in critically ill patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection. [PDF]

Sci Rep, 2022
Lu X, Guo Z, Li ZN, Holiday C, Liu F, Jefferson S, Gross FL, Tzeng WP, Kumar A, York IA, Uyeki TM, Tumpey T, Stevens J, Levine MZ.   +13 more
europepmc   +1 more source

The free-living ciliate Tetrahymena pyriformis inactivates engulfed influenza A(H1N1)pdm09 virus via two distinct types of endosomes. [PDF]

Sci Rep
Pushkareva VI, Krepkaia AS, Ignatieva AV, Shevlyagina NV, Andreevskaya SG, Fofanova E, Sysolyatina EV, Zhukhovitsky VG, Burtseva EI, Ermolaeva SA.   +9 more
europepmc   +1 more source

Determination of Hemagglutinin and Neuraminidase Genetic Variation of Human Influenza A(H1N1)pdm09 Virus Strain Isolated From Deceased Patients in Shiraz, Iran: A Cross-Sectional Study. [PDF]

Health Sci Rep
Barkhori R, Edalat F, Pirbonyeh N, Goudarzi Y, Hosseini SY, Moattari A.   +5 more
europepmc   +1 more source

Evaluation of in-vitro antiviral potential of <i>Psidium guajava</i> L. Extract against influenza A/(H1N1)pdm09 virus. [PDF]

Virusdisease
Boora S, Wadhwa S, Lath A, Khan A, Kumar P, Gill P, Kumar D, Kaushik S.   +7 more
europepmc   +1 more source

A High-Yield Recombinant Inactivated Whole-Virion Nasal Influenza A(H1N1)pdm09 Virus Vaccine with an Attenuated PB2 Gene. [PDF]

Int J Mol Sci
Son SE, Song JH, Kim HW, An SH, Kim SJ, Lee CY, Kwon HJ, Choi KS.   +7 more
europepmc   +1 more source